Integrating Neoadjuvant Immunotherapy in Head & Neck Cancer Care

Published Grace Chan on

ClinicalTranslationalNetwork

This forum brought together multidisciplinary cancer care teams to build capability in the safe and effective integration of neoadjuvant immunotherapy for head and neck cancers. Participants explored emerging evidence, patient selection, treatment sequencing and toxicity management to support coordinated decision-making and greater consistency in clinical practice.

Watch on demand

Event recording

At a glance

The event in brief

Originally held

Thursday 23 July 2026

Science Gallery Melbourne and online via Zoom.

Who this is for

Multidisciplinary cancer care teams

Head and neck surgeons, medical and radiation oncologists, cancer nurses, allied health professionals and other clinicians involved in the care of patients with resectable head and neck cancer.

Contributors

Chair and speakers

Prof Ben Dixon

Chair

Prof Ben Dixon

Director/Head of Unit, ENT Head & Neck department, St Vincent's Hospital Melbourne; Garnett Passe & Rodney Williams Professor of Otolaryngology Head & Neck Surgery, University of Melbourne

Prof Dixon is an ENT Surgeon specialising in Head and Neck Oncology and Skull Base Surgery. He completed his FRACS in Otolaryngology, Head and Neck Surgery in Victoria. Following this, he spent two years at the University of Toronto undertaking a fellowship in Head & Neck Oncology, Endoscopic Skull Base Surgery, Microvascular Reconstruction and Thyroid Surgery. After further training in Transoral Robotic Surgery at the University of Pennsylvania he established the TORS program at Peter MacCallum Cancer Centre. 

Dr Alesha Thai

Speaker

Dr Alesha Thai

Medical Oncologist, Peter MacCallum Cancer Centre and Austin Health

Dr Thai's research investigates the interplay between the tumor microenvironment, the host immune system, and viral causes of head and neck cancer. She places a strong emphasis on improving disparities in patient care, especially for patients from culturally and linguistically diverse backgrounds.

A/Prof Martin Batstone

Speaker

A/Prof Martin Batstone

Director of the Royal Brisbane and Women’s Hospital Maxillofacial Unit

Associate Professor Martin Batstone completed his Medical and Dental degrees at the University of Queensland and was a graduate of the Queensland Oral and Maxillofacial surgery training program. This was followed by three years of additional training in head and neck cancer surgery in Liverpool in the UK culminating in a Fellowship of the Royal College of Surgeons of England. He practices the whole scope of oral and maxillofacial surgery with a special interest in head and neck cancer and reconstructive surgery.

Panellists

Dr Kevin Nguyen

ENT Surgeon, The Royal Melbourne Hospital, Peter MacCallum Cancer Centre and Eastern Health

Dr Tsien Fua

Head and Neck Radiation Oncologist, Peter MacCallum Cancer Centre


Event partner

MSD provided financial support for this event. Content was developed independently by the VCCC Alliance and the presenting faculty.

Resource details

Picture of people reading at symposium
Course type
Webinars
Duration
1 hr 30 mins
Price
$0.00
Curriculum Area
Prevention, screening and diagnostics
Treatment (incl. Supportive Care)
Monitoring and Surveillance
Research (incl. Clinical Trials)
Clinical Care
Speciality
Administration/Executive
Allied Health professional
Clinician
Early to mid career researcher
GP
Nurse
Senior researcher / scientist
Clinical care
Equity and inclusion
Head and neck
Immunotherapy
Monday Lunch Live
Regional
Research
Tailored screening

This course is brought to you by

Alliance members